Inaktiver Wert

Epirus Biopharmaceuticals Inc Aktie Nasdaq

Aktien

Dauer

Zeitraum

Stil

Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016	15.03.16
Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015	16.11.15
Transcript : EPIRUS Biopharmaceuticals, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 01:20 PM	11.08.15
Transcript : EPIRUS Biopharmaceuticals, Inc., Zalicus Inc. - M&A Call	16.04.14

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09.10.18
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	31.01.18
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19.01.18
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	18.01.18
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11.12.17

EPIRUS Biopharmaceuticals, Inc. befindet sich im Konkursverfahren.

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	+1.51%	42.59 Mrd.
MODERNA, INC.	+8.57%	40.65 Mrd.
LONZA GROUP AG	+49.22%	40.57 Mrd.
CELLTRION, INC.	-12.36%	26.77 Mrd.
ICON PUBLIC LIMITED COMPANY	+8.92%	24.81 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.17 Mrd.
MEDPACE HOLDINGS, INC.	+29.17%	12.05 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.7 Mrd.
UNITED THERAPEUTICS CORPORATION	+6.35%	11.1 Mrd.